Veterinary Coagulation Analyzer NX-102

NX-102

Point of origin: China CE ISO13485
Testing item: PT/INR,APTT,TT,FIB,ACT
Throughput: 30T/H
Application scenarios: veterinary hospital ;pet ICU ;animal clinic

The Veterinary Coagulation Analyzer NX-102 is a portable, reliable, and efficient tool designed for veterinary diagnostics. Here are the key points summarizing its features and applications:

Key Features:

Portability:

Small Footprint: Weighs only 2 lbs, making it highly portable.
Rechargeable Battery: Can be used in various settings without the need for a constant power supply.

Convenience:

One-step Process: No additional accessories required, simplifying the testing process.
Maintenance-free: Designed to be maintenance-free, reducing operational costs and effort.

Fast and Reliable:

Rapid Results: Provides results in 3 minutes or less.
Precision: Coefficient of Variation (CV) ≤ 5%, ensuring reliable and consistent results.

Applications:

Screening Tests:

Exogenous and Endogenous Coagulation System: Assesses the function of coagulation systems in canines and felines.

Monitoring:

Anticoagulant Treatment: Ensures the effectiveness and safety of anticoagulant therapy.
Thrombolytic Therapy: Monitors the efficacy of thrombolytic treatments.
Certain Diseases: Tracks coagulation status in patients with conditions such as hepatopathy, infections, and burn injuries.

Tests Supported:

PT/INR (Prothrombin Time/International Normalized Ratio)
APTT (Activated Partial Thromboplastin Time)
TT (Thrombin Time)
FIB (Fibrinogen)
ACT (Activated Clotting Time)

Sample Requirements:

Sample Type: Citrated venous whole blood or capillary blood (PT/INR only).
Sample Volume: 20 μL.

Performance:

Time to Result: 5 minutes.
Precision: CV ≤ 5%.
Storage: Reagents are valid for 18 months at room temperature.

ltems Sample Types Sample Size			Reference Range
PT	Whole Blood	20uL	C anine: 5-15s	Feline: 6-1 5s
NR	Whole Blood	20uL	C anine: 0.5-1.6	Feline: 0.6-1.6
APT T	Whole Blood	20pL	C anine: 15-45s	Feline:15-43s
TT	Whole Blood	20pL	C anine: 8-20s	Feline: 9-22s
FIB	Whole Blood	20uL	Canine: 1-3g/L	Feline: 1-2.5g/L
AC;T	Whole Blood	20uL	C anine: 50-1 50s	Feline: 50-1 60sL

Product Description
Performance Parameters

The Veterinary Coagulation Analyzer NX-102, with its ability to perform PT/INR, APTT, TT, FIB, and ACT tests, is a versatile and essential tool in veterinary practice, providing rapid, reliable, and precise diagnostics for a wide range of clinical applications.

Veterinary Clinics and Hospitals:

Routine coagulation screening for various animals.
Monitoring of anticoagulant and thrombolytic therapies.
Pre-surgical screening to ensure safe surgical outcomes.

1. Prothrombin Time/International Normalized Ratio (PT/INR)

Clinical Applications:

Anticoagulant Therapy Monitoring: Regularly used to monitor patients on warfarin therapy to ensure proper dosing and prevent complications like bleeding or thrombosis.
Liver Function Assessment: PT/INR can indicate liver disease, as the liver synthesizes clotting factors. Elevated PT/INR suggests impaired liver function.
Coagulation Disorders: Used to diagnose bleeding disorders such as hemophilia, von Willebrand disease, and other factor deficiencies.
Pre-Surgical Screening: Assesses the coagulation status before surgical procedures to minimize bleeding risks.

2. Activated Partial Thromboplastin Time (APTT)

Clinical Applications:

Heparin Therapy Monitoring: Essential for monitoring patients receiving unfractionated heparin to adjust dosage and avoid complications.
Coagulation Factor Deficiencies: Helps diagnose deficiencies in intrinsic pathway factors such as factors VIII, IX, XI, and XII.
Lupus Anticoagulant Testing: Elevated APTT may indicate the presence of lupus anticoagulant, an autoimmune disorder.
Pre-Surgical Screening: Used to evaluate bleeding risk before surgeries, especially in patients with known or suspected coagulation disorders.

3. Thrombin Time (TT)

Clinical Applications:

Fibrinogen Function: Assesses the final step of the coagulation process, where fibrinogen is converted to fibrin by thrombin. Prolonged TT indicates issues with fibrinogen function.
Heparin Presence: Prolonged TT can indicate the presence of heparin or direct thrombin inhibitors in the blood.
Dysfibrinogenemia: Identifies qualitative abnormalities of fibrinogen, which can be inherited or acquired.

4. Fibrinogen (FIB)

Clinical Applications:

Assessing Clot Strength: Fibrinogen levels directly affect the strength and stability of clots. Low levels indicate an increased risk of bleeding.
Disseminated Intravascular Coagulation (DIC): Used to diagnose and monitor DIC, a condition characterized by widespread clotting and bleeding.
Liver Disease and Inflammatory States: Evaluates liver function and acute phase reactions, as fibrinogen is a liver-synthesized acute-phase protein.
Cardiovascular Risk: Elevated fibrinogen levels are associated with an increased risk of cardiovascular diseases.

5. Activated Clotting Time (ACT)

Clinical Applications:

Heparin Monitoring during Procedures: Primarily used during surgeries requiring high doses of heparin, such as cardiopulmonary bypass or dialysis, to ensure effective anticoagulation.
Rapid Assessment in Emergency Situations: Provides quick evaluation of the coagulation status in trauma patients or during critical care.
Point-of-Care Testing: Convenient for bedside or intraoperative monitoring of anticoagulation status.